journal article·2020

Adsorption of proteins on oral Zn 2+ doped iron oxide nanoparticles in mouse stomach and in vitro : triggering nanoparticle aggregation

Xiaoqin Wang, Jiachun Gong, Weihang Tan, Tingting Hu, Rui Rong, Zongxiang Gui, Kai Nie, Xiaolong Xu

Nanoscale· Volume 12· Issue 44
Publisher page

Abstract

Oral route is one of the most important portals of nanoparticle entry to the body. However, in vivo protein corona formed in the gastrointestinal tract has not been studied owing to the difficulty for the recovery of nanoparticles from the in vivo environment. In this study, by using the magnetic property of iron oxide nanoparticles (Fe3O4 NPs) and Zn2+ doped iron oxide nanoparticles (Zn0.4Fe2.6O4 NPs), the nanoparticles were separated from the gastric fluid after oral administration in mice. The effects of Zn2+ doping and static magnetic field (SMF) treatment on the protein adsorption on the nanoparticles were investigated in vitro and in vivo. Zn2+ doping decreases the adsorption of pepsin on the nanoparticles in vitro and affects the composition of the protein corona in vivo and enhances protein adsorption-induced aggregation of the nanoparticles in vitro and in vivo. SMF treatment affects the composition of the protein corona of Fe3O4 NPs and Zn0.4Fe2.6O4 NPs, and enhances the aggregation of Fe3O4 NPs and Zn0.4Fe2.6O4 NPs in vivo. Furthermore, the results demonstrate that electrostatic attraction is the crucial force to drive adsorption of proteins on Fe3O4 NPs and Zn0.4Fe2.6O4 NPs and protein adsorption-induced change in the surface charge of nanoparticles plays an important role in the pH-dependent aggregation of the nanoparticles. In addition, the work provides the evidence that the protein adsorption-induced aggregation of Fe3O4 NPs and Zn0.4Fe2.6O4 NPs has no effect on their magnetic susceptibility. The results highlight that Zn0.4Fe2.6O4 NPs may be used as a potential oral magnetic resonance imaging contrast agent in diagnosis of gastrointestinal disease.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Iron Metabolism and Disorders · Blood properties and coagulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry

University of Science and Technology of China

Hefei

P. R. China

National Synchrotron Radiation Laboratory

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China · University of Science and Technology of China

References (45)

Show source-provided references
1. Jedlovszky-Hajdu · Langmuir · 2012 · 28 · 1498310.1021/la302446h ↗
2. Kihara · Bioconjugate Chem. · 2019 · 30 · 106710.1021/acs.bioconjchem.9b00015 ↗
3. Simon · Nanoscale · 2018 · 10 · 2109610.1039/C8NR07424K ↗
4. Stepien · ACS Appl. Mater. Interfaces · 2018 · 10 · 454810.1021/acsami.7b18648 ↗
5. Lee · Int. J. Nanomed. · 2015 · 10 · 97
6. Choi · Nanotoxicology · 2017 · 11 · 6410.1080/17435390.2016.1264638 ↗
7. Shcharbin · Colloids Surf., B · 2015 · 134 · 37710.1016/j.colsurfb.2015.07.017 ↗
8. Lira · Nanoscale · 2018 · 10 · 323510.1039/C7NR06810G ↗
9. Moustaoui · Nanoscale · 2019 · 11 · 366510.1039/C8NR09891C ↗
10. Hadjidemetriou · ACS Nano · 2015 · 9 · 814210.1021/acsnano.5b03300 ↗
11. Corbo · ACS Nano · 2017 · 11 · 326210.1021/acsnano.7b00376 ↗
12. Sakulkhu · Nanoscale · 2014 · 6 · 1143910.1039/C4NR02793K ↗
13. Kapralov · ACS Nano · 2012 · 6 · 414710.1021/nn300626q ↗
14. Besinis · ACS Nano · 2015 · 9 · 225510.1021/nn505015e ↗
15. Wang · Small · 2013 · 9 · 174210.1002/smll.201201185 ↗
16. Wang · Toxicol. Lett. · 2007 · 168 · 17610.1016/j.toxlet.2006.12.001 ↗
17. Kumari · Drug Chem. Toxicol. · 2013 · 36 · 29610.3109/01480545.2012.720988 ↗
18. Zimmermann · Nanoscale · 2011 · 3 · 239010.1039/c0nr00858c ↗
19. Ahamed · Toxicol. in Vitro · 2019 · 57 · 1810.1016/j.tiv.2019.02.004 ↗
20. Chee · ACS Nano · 2018 · 12 · 648010.1021/acsnano.7b07572 ↗
21. Hahn · Radiology · 1990 · 175 · 69510.1148/radiology.175.3.2343116 ↗
22. Zhu · Toxicol. In Vitro · 2010 · 24 · 163910.1016/j.tiv.2010.06.002 ↗
23. Ault · Environ. Sci.: Nano · 2016 · 3 · 1510
24. Yang · J. Chromatogr. A · 2017 · 1513 · 11810.1016/j.chroma.2017.07.026 ↗
25. Bhattacharya · Nanomedicine · 2016 · 12 · 33310.1016/j.nano.2015.11.011 ↗
26. Lopes · RSC Adv. · 2016 · 6 · 2015510.1039/C5RA26224K ↗
27. Wen · Part. Fibre Toxicol. · 2019 · 16 · 3010.1186/s12989-019-0314-4 ↗
28. Sukumar · Biomaterials · 2019 · 218 · 11934210.1016/j.biomaterials.2019.119342 ↗
29. Villaraza · Chem. Rev. · 2010 · 110 · 292110.1021/cr900232t ↗
30. Kim · J. Am. Chem. Soc. · 2011 · 133 · 1262410.1021/ja203340u ↗
31. Jang · Angew. Chem., Int. Ed. · 2009 · 48 · 123410.1002/anie.200805149 ↗
32. Zhu · Toxicol. Res. · 2016 · 5 · 9710.1039/C5TX00292C ↗
33. Chen · Colloids Surf., A · 2008 · 316 · 21010.1016/j.colsurfa.2007.09.017 ↗
34. Liang · Colloid Polym. Sci. · 2007 · 285 · 119310.1007/s00396-007-1672-2 ↗
35. Wang · Bioresour. Technol. · 2008 · 99 · 388110.1016/j.biortech.2007.08.017 ↗
36. Muto · J. Biochem. · 1980 · 87 · 71710.1093/oxfordjournals.jbchem.a132800 ↗
37. Ding · Nano Res. · 2019 · 12 · 12910.1007/s12274-018-2191-9 ↗
38. Breitner · Nanotechnology · 2018 · 29 · 25400110.1088/1361-6528/aabb9d ↗
39. Gunnarsson · Nanoscale · 2018 · 10 · 424610.1039/C7NR08696B ↗
40. Wang · Mater. Sci. Eng., C · 2019 · 103 · 10985610.1016/j.msec.2019.109856 ↗
41. Rong · Chem. Eng. J. · 2016 · 291 · 2010.1016/j.cej.2016.01.082 ↗
42. Bohorquez · Part. Part. Syst. Charact. · 2014 · 31 · 56110.1002/ppsc.201300296 ↗
43. Dominguez-Medina · ACS Nano · 2016 · 10 · 210310.1021/acsnano.5b06439 ↗
44. Cukalevski · Nano Res. · 2015 · 8 · 273310.1007/s12274-015-0780-4 ↗
45. Curnutt · Sci. Rep. · 2020 · 10 · 876010.1038/s41598-020-65392-4 ↗